Harrow, Inc. Defined Contribution Plan, Employer Matching Contribution, Percent of Match
Harrow, Inc. (HROW) reported Defined Contribution Plan, Employer Matching Contribution, Percent of Match of 4.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Compensation Related Costs › Retirement Benefits
us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch · last filed 2026-03-02
- Harrow, Inc. defined contribution plan, employer matching contribution, percent of match for fiscal 2025 was 4.00%, a 0.00% change from fiscal 2024.
- Harrow, Inc. defined contribution plan, employer matching contribution, percent of match for fiscal 2024 was 4.00%, a 0.00% change from fiscal 2023.
- Harrow, Inc. defined contribution plan, employer matching contribution, percent of match for fiscal 2023 was 4.00%, a 0.00% change from fiscal 2022.
- Harrow, Inc. defined contribution plan, employer matching contribution, percent of match for fiscal 2022 was 4.00%, a 0.00% change from fiscal 2021.
| Period end | Defined Contribution Plan, Employer Matching Contribution, Percent of Match 12 month |
|---|---|
| 2025-12-31 | 4.00% 10-K · filed 2026-03-02 |
| 2024-12-31 | 4.00% 10-K · filed 2025-03-27 |
| 2023-12-31 | 4.00% 10-K · filed 2024-03-19 |
| 2022-12-31 | 4.00% 10-K · filed 2023-03-23 |
| 2021-12-31 | 4.00% 10-K · filed 2022-03-10 |
| 2020-12-31 | 4.00% 10-K · filed 2021-03-08 |
| 2019-12-31 | 4.00% 10-K · filed 2020-03-13 |
| 2018-12-31 | 4.00% 10-K · filed 2020-03-13 |
| 2017-12-31 | 4.00% 10-K · filed 2019-03-12 |
| 2016-12-31 | 4.00% 10-K · filed 2017-03-21 |
| 2015-12-31 | 4.00% 10-K · filed 2016-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |